newsfilter
← Latest News
GlobeNewswire·

Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer

WELLESLEY HILLS, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (NASDAQ:CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has